Snap Inc. SNAP

Snap Inc. es una empresa de cámaras. El producto estrella de la empresa, Snapchat, es una aplicación de cámara que ayuda a las personas a comunicarse a través de videos cortos e imágenes conocidos como Snap. Snapchat consta de cinco pestañas: Cámara, Comunicación, Mapa de Snap, Historias y Spotlight. La Cámara es el punto de partida para la creación en Snapchat. Snapchat se abre directamente a la Cámara, ayudando a crear un Snap y enviarlo a amigos. La Comunicación permite a los usuarios enviar mensajes a través de texto, Snaps y llamadas de voz o video a amigos de forma colectiva o individual. El Mapa de Snap es un mapa en vivo y personalizado que permite a los Snapchatters conectarse con amigos y explorar lo que está sucediendo en su área local. Las Historias presentan contenido de amigos de Snapchatters, la comunidad de la empresa y socios de contenido. Spotlight es una forma de compartir contenido generado por usuarios con toda la comunidad de Snapchat. Los productos publicitarios de la empresa incluyen Snap Ads y anuncios de realidad aumentada (AR).

• GlobeNewswire Inc. 2 oct

  1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

  Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

  

• GlobeNewswire Inc. 30 sept

  Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit—HBSS

  Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

  

• Zacks Investment Research 29 sept

  Snap (SNAP) Rises As Market Takes a Dip: Key Facts

  Snap (SNAP) closed at $5.34, up 2.3% in the latest session, outperforming the broader market. The company is expected to report EPS of $0.16 (up 166.67% YoY) and quarterly revenue of $1.72 billion (up 14.33% YoY). Trading at a Forward P/E of 8.9 versus the industry average of 19.04, Snap appears undervalued. However, the stock holds a Zacks Rank of #3 (Hold) with steady consensus estimates over the past month.

  

• GlobeNewswire Inc. 26 sept

  Upcoming Blaze Wilde Podcast on Snapchat Exploring Pop Culture, Politics, and Life Between Arab and American Culture

  cauZmik Inc is launching a new Snapchat podcast in partnership with Los Angeles-based model and creator Blaze Wilde in October 2026. The podcast will feature candid conversations about pop culture, politics, Arab identity, and Wilde's experiences living between the UAE and the United States, drawing from his modeling career and social media presence.

  

• GlobeNewswire Inc. 25 sept

  HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm

  A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap, and charging consumers for prescriptions without proper consultation. The stock declined 14.73% on the news, dropping $4.32 per share to $25.00 on July 29, 2026.